HMT expands global footprint with export despatch to South Africa (See 'Corp Brief') Govt highlights achievements in empowering Micro Food Processing Enterprises, women entrepreneurs & rural livelihoods (See 'Corp Brief') SAIL signs MoU with MDI, Gurgaon for Executive Education Program (See 'Corp Brief') Govt hosts Bharat Innovates Investor Showcase; 24 deep-tech start-ups participate (See 'Corp Brief') SARFAESI - Pre-deposit u/s 18 of SARFAESI Act cannot be completely waived for entertaining appeal before DRAT: HC (See 'Legal Desk') SEBI, NISM & IICA sign MoU to advance corporate covernance, ESG (See 'Corp Brief') BRICS Youth Council Entrepreneurship Working Group concludes discussions on innovation & sustainable enterprise (See 'Corp Brief') Misc - Embargo under RBI Master Circular dated July 1, 2015 cannot be mechanically continued for five years after removal of borrower's name from list of wilful defaulters if account was settled by compromise: HC (See 'Legal Desk') Women participation under APY reaches record 55.14% during FY 2025-26 (See 'Corp Brief') National Review Meeting for Swachh Bharat Mission-Urban 2.0 to be held in New Delhi (See 'Corp Brief') Gadkari reviews progress and Quality of NH Projects in Assam (See 'Corp Brief') CCI approves acquisition of equity in Neysa Networks by BCP Asia II Topco V Pte. (See 'Corp Brief') IPR - If patent claim is only to device embodied in chip, royalty or damages cannot be assessed on basis of entire end product: HC (See 'Legal Desk') CCI okays acquisition of stake of Restaurant Brands Asia by Lenexis Foodworks (See 'Corp Brief') CCI nod for acquisition of Baharampore-Farakka Highways Toll Roads by Cube Highways Trust (See 'Corp Brief') India, South Korea sign agreements for cooperation in Defence Cyber (See 'Corp Brief') Scindia launches Mission on 'Arunachal Kiwi: The USP of Arunachal Pradesh' (See 'Corp Brief') A&C - Invocation of arbitration u/s 21 is not consent to appointment, and that subsequent participation in proceedings does not by itself constitute express written waiver: HC (See 'Legal Desk') DFS organises Half-Day Workshop on IBC Amendment Act, 2026 (See 'Corp Brief') National Seminar on 'New Age Fibres – Innovation, Research and the Road Ahead' inaugurated (See 'Corp Brief') National Commission for Minorities organizes Conference of State Minorities Commissions (See 'Corp Brief') IPR - Sec 17 of Trade Marks Act does not prevent protection of prominent part of composite mark where that part is distinctive: HC (See 'Legal Desk') MoS launches Ayush Anudan Portal under Ayush Grid Initiative (See 'Corp Brief') Coal Production commences from Urtan and Dhirauli Mines in MP (See 'Corp Brief') Govt's TEAM Initiative empowering Small Businesses through Digital Commerce Enablement (See 'Corp Brief') PMLA - Provisional attachment not invalidated due to lack of competency of officer; amended provisions do not apply to transactions prior to 2016 amendment if property continues to be held: SAFEMA (See 'Legal Desk') MoRD charts roadmap for Women-Led Rural Marketing Ecosystems (See 'Corp Brief') Pharmacopoeia Commission organizes 5-Day Capacity Building Training (See 'Corp Brief') Saurabh Vijay assumes charge as CEO of Unique Identification Authority of India (See 'Corp Brief') Companies Act - Appellant company directed to change its name where it significantly resembles the name of a pre-existing company and may cause confusion: HC (See 'Legal Desk') Minister reviews technology-led underground mining, integrated smelting operations (See 'Corp Brief') Scientific Steering Committee Meeting on National One Health Mission Held in New Delhi (See 'Corp Brief') Govt launches campaign to reduce edible oil consumption (See 'Corp Brief') PMLA - Provisional attachment unsustainable when Initiating Officer fails to establish source of consideration & beneficial ownership as per Section 2(9)(A): SAFEMA (See 'Legal Desk') HM inaugurates 'Million Minds Tech Park' and 'GREMI City Campus' in Ahmedabad (See 'Corp Brief') Amit Shah inaugurates State-of-the-Art Milk Processing Plant of Madhur Dairy (See 'Corp Brief') Experts Discuss Yoga for Youth and Mental Wellness in Digital Era (See 'Corp Brief') Misc - RBI circular dated June 07, 2019 on 'Prudential Framework for Resolution of Stressed Assets' was policy decision taken by expert body in larger public interest: HC (See 'Legal Desk') GeM continues to support Digital Public Procurement System (See 'Corp Brief') Ministry of Education reviews strategy for mainstreaming Out-of-School children (See 'Corp Brief') Misc - NBFC cannot reposses financed vehicle through coercive means, without adherence to due process of law and in violation of RBI recovery guidelines: HC (See 'Legal Desk') Supreme Court lays down scenarios for lifting of Doctrine of Corporate Veil (See 'CORP EINSICHTf')

Print

MoS reaffirms India's commitment to global pharmaceutical standardization

Published: Feb 06, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 06, 2025: UNION Minister of State for Health and Family Welfare, Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO), here today. The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonization.

Addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardization and regulatory convergence. She highlighted India's role as the "Pharmacy of the World" and emphasized the importance of ensuring access to high-quality medicines globally. She stated that the IMWP serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization.

On this occasion, the Union Minister also released the IPC Newsletter 2024 and a special IPC video film, which showcase India's advancements in pharmacopoeial science and the Commission's efforts in ensuring high-quality pharmaceutical standards. The video film can be accessed at the following link: https://www.youtube.com/watch?v=MCdAZodvOSM .

Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, underscored the significance of global partnerships in strengthening pharmaceutical quality standards. She reiterated India's efforts in aligning regulatory frameworks with international best practices and ensuring the availability of safe and effective medicines worldwide.

Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC, and Drugs Controller General (India), highlighted IPC's contributions in setting global benchmarks in pharmacopoeial science. He elaborated on IPC's initiatives, including the IP Online platform, which enhances accessibility and usability of Indian Pharmacopoeia standards. He emphasized the role of scientific advancements and regulatory cooperation in shaping global pharmaceutical standards.

Dr. Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasized the importance of regulatory harmonization in ensuring patient safety and public health.

The 15th IMWP is set to facilitate discussions on key focus areas, including:

- Updates on recommendations from the 14th IMWP and review of progress on harmonization initiatives.

- Emerging issues in impurity assessment (Q3) and the implications of ICH Q6 guidelines on pharmacopoeial monograph specifications.

- Defining the IMWP Charter to establish a long-term governance structure for the forum.

- Enhancing collaboration among global pharmacopoeias and regulatory bodies, with updates from the Pharmacopoeial Discussion Group (PDG).

- Promotion of environmental sustainability in pharmacopoeial practices and pharmaceutical manufacturing standards.

- Finalization of reports for the 15th IMWP and preparatory discussions for the 16th IMWP.

The deliberations during the IMWP will reinforce the role of pharmacopoeias in ensuring the quality, safety, and efficacy of medicines. The outcomes of the meeting will guide future collaborations in standard-setting and regulatory harmonization.

The 15th IMWP, which commenced today, will conclude on 7th February 2025. The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.